Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies
Article in Pharmaceutical Science Advances (December 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling
Article in International Immunopharmacology (April 2024)
Hemisynthesis and cytotoxic evaluation of manoyl oxide analogs from sclareol: effect of two tertiary hydroxyls & Heck coupling on cytotoxicity
Article in Natural Product Research (April 2024)